WOBURN, Mass., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Neurogastrx, Inc., today presented proof-of-concept data from its placebo-controlled Phase 2 clinical study of NG101 (metopimazine mesylate), an oral, ...
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in ...
Study Comparing Intranasal Powder Formulation of Ondansetron Demonstrates Comparable Pharmacokinetic Profile to Intravenous Ondansetron in Animal ...
On hospital day 2, an EGD showed extensive esophagitis as well as a 3-cm wide opening in the distal esophagus at 32 cm from the incisors, exposing multiple bronchi (Figures 5 and 6). Figure 5: EGD at ...
Oral Cannabis Extract for Secondary Prevention of Chemotherapy-Induced Nausea and Vomiting: Final Results of a Randomized, Placebo-Controlled, Phase II/III Trial From March 2022 to December 2023, a ...
Doctors are reporting a growing number of people coming into emergency rooms with stomach pain and unrelenting vomiting. They compulsively take hot showers. Anti-nausea medication offers little relief ...
The FDA approved a new pill called Nereus (tradipitant) that can prevent vomiting caused by motion sickness. In clinical trials, Nereus helped up to 90 percent of people prone to motion sickness avoid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results